Alto Ingredients regains Nasdaq compliance as share price tops $1

Alto Ingredients (Nasdaq:ALTO) filed an 8-K announcing it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common-stock bid price closed above $1.00 for 10 consecutive business days.

Rhea-AI Filing Summary

Alto Ingredients (Nasdaq:ALTO) filed an 8-K announcing it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common-stock bid price closed above $1.00 for 10 consecutive business days. Nasdaq’s letter dated June 23, 2025 states the deficiency is cured and the matter is closed.

The decision removes the immediate delisting threat and secures ALTO’s position on the Nasdaq Capital Market. No financial or operational updates were provided in the filing.

Positive

• Nasdaq compliance restored after bid price stayed above $1 for 10 consecutive days, removing delisting risk and preserving market listing.

Negative

• None.

Insights

Event Analyst

TL;DR: Delisting risk lifted; Nasdaq compliance restored.

With compliance regained, liquidity and investor confidence improve because many institutions require Nasdaq listing. The company avoids forced actions such as a reverse split and retains flexibility for future capital raises. While fundamentals are unchanged, the governance overhang is gone, potentially narrowing the discount previously applied to the shares. Sustainability remains the key watch-item, as the bid price buffer above $1 is likely modest.

Risk Analyst

TL;DR: Compliance positive, but stability unproven.

The 10-day $1 threshold was met, yet absent new earnings or strategy disclosures, price support could be fragile. A market pullback could quickly revive deficiency risk, forcing costly remedies like a reverse split. Investors should track volume trends and upcoming catalysts to gauge whether the share price can remain comfortably above the rule’s floor.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When did Alto Ingredients receive Nasdaq's compliance confirmation?

The company received Nasdaq's letter on June 23, 2025.

Which Nasdaq rule did ALTO regain compliance with?

Nasdaq Listing Rule 5550(a)(2), requiring a minimum $1.00 bid price.

How did Alto Ingredients cure its bid-price deficiency?

ALTO’s common stock closed above $1.00 for 10 consecutive business days.

What is the immediate impact on ALTO's listing status?

Nasdaq closed the matter, so ALTO remains listed on the Nasdaq Capital Market with no delisting proceedings pending.

Does the 8-K include any financial or operational updates?

No. The filing solely addresses the restoration of listing compliance; no financial results were disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/27/2025 - 08:30 AM Learn about SEC filing dates

false 0000778164 0000778164 2025-06-23 2025-06-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 23, 2025

ALTO INGREDIENTS, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware		000-21467		41-2170618
(State or Other Jurisdiction		(Commission File Number)		(IRS Employer
of Incorporation)				Identification No.)

1300 South Second Street Pekin, Illinois		61554
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (916) 403-2123

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value		ALTO		The Nasdaq Stock Market LLC (Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events

On June 23, 2025, Alto Ingredients, Inc. (the “Company”) received a letter from the listing qualifications staff of The Nasdaq Stock Market (“Nasdaq”) indicating that the bid price of the Company’s common stock for the last 10 consecutive business days had closed above the minimum $1.00 per share required to regain compliance for continued listing under Nasdaq Listing Rule 5550(a)(2).

Nasdaq stated in its letter than the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter is closed.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 27, 2025	ALTO INGREDIENTS, INC.
	By:	/s/ AUSTE M. GRAHAM
		Auste M. Graham,
		Chief Legal Officer & Secretary

2